|
WO1999048858A2
(en)
*
|
1998-03-26 |
1999-09-30 |
University Of Saskatchewan Technologies Inc. |
Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents
|
|
US6984754B1
(en)
|
1998-03-26 |
2006-01-10 |
University Of Saskatchewan Technologies Inc. |
Aliphatic amino carboxylic and amino phosphonic acids amino nitriles and amino tetrazoles as cellular rescue agents
|
|
DK1073432T3
(da)
*
|
1998-04-14 |
2007-12-17 |
Gen Hospital Corp |
Anvendelse af D serin eller D alanin til behandling af skizofreni
|
|
TW555757B
(en)
|
1998-07-31 |
2003-10-01 |
Akzo Nobel Nv |
Aminomethylcarboxylic acid derivatives
|
|
DE19840611A1
(de)
*
|
1998-09-05 |
2000-03-09 |
Klaus Wanner |
GABA-uptake-Inhibitoren mit Pyrrolidinstruktur
|
|
WO2001002363A2
(en)
*
|
1999-07-06 |
2001-01-11 |
Vertex Pharmaceuticals Incorporated |
N-substituted glycine derivatives
|
|
TWI243173B
(en)
|
1999-11-17 |
2005-11-11 |
Akzo Nobel Nv |
Spiro[2H-1-benzopyran-2,4'-piperidine] derivatives
|
|
DOP2001000189A
(es)
|
2000-06-30 |
2002-03-30 |
Pfizer Prod Inc |
Benzofenonas y sulfonas como inhibidores de la captación de glicina
|
|
US20020120149A1
(en)
|
2000-09-08 |
2002-08-29 |
Ali Syed M. |
Substituted hydrazine derivatives
|
|
WO2002022581A1
(en)
*
|
2000-09-14 |
2002-03-21 |
Gliatech, Inc. |
Nitrogen-containing compounds and their use as glycine transport inhibitors
|
|
AR032653A1
(es)
|
2001-02-09 |
2003-11-19 |
Telik Inc |
Inhibidores heterociclicos del trasportador de glicina 2 composiciones farmaceuticas, uso y metodos.
|
|
CN1219776C
(zh)
*
|
2001-02-16 |
2005-09-21 |
阿雷里克斯神经学有限公司 |
作为glyt－1抑制剂的噻吩取代的胺衍生物
|
|
US6566550B2
(en)
|
2001-06-21 |
2003-05-20 |
Pfizer Inc |
Substituted aromatic ethers as inhibitors of glycine transport
|
|
DE60206454T2
(de)
|
2001-08-16 |
2006-06-29 |
Pfizer Products Inc., Groton |
Difluormethylen aromatische Ether und ihre Verwendung als Inhibitoren des Glycin-Typ-1-Transporters
|
|
AU2002347906A2
(en)
|
2001-10-16 |
2003-04-28 |
Hypnion, Inc. |
Treatment of CNS disorders using CNS target modulators
|
|
US7189757B2
(en)
|
2001-10-16 |
2007-03-13 |
Hypnion, Inc. |
Treatment of sleep disorders using CNS target modulators
|
|
US7355042B2
(en)
|
2001-10-16 |
2008-04-08 |
Hypnion, Inc. |
Treatment of CNS disorders using CNS target modulators
|
|
GB0219153D0
(en)
*
|
2002-08-16 |
2002-09-25 |
Pfizer Ltd |
Substituted glycine derivatives for use as medicaments
|
|
AU2003287023A1
(en)
|
2002-11-05 |
2004-06-03 |
Eli Lilly And Company |
3-aryloxy/ thio-2, 3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake
|
|
CN100439330C
(zh)
*
|
2003-04-30 |
2008-12-03 |
H.隆德贝克有限公司 |
芳族羟苯基和芳族硫基苯基衍生物
|
|
CN1867358A
(zh)
*
|
2003-08-21 |
2006-11-22 |
H.隆德贝克有限公司 |
用于治疗抑郁症的5－羟色胺再摄取抑制剂和1型甘氨酸转运蛋白抑制剂的联合药物
|
|
US20050080100A1
(en)
*
|
2003-10-09 |
2005-04-14 |
Pfizer Inc |
Pyridylamino compounds and methods of use thereof
|
|
US7473787B2
(en)
|
2003-10-14 |
2009-01-06 |
Pfizer Inc |
Bicyclic [3.1.0] derivatives as glycine transporter inhibitors
|
|
EP1727785A1
(en)
*
|
2004-03-12 |
2006-12-06 |
H.Lundbeck A/S |
Phenyl indan derivatives
|
|
WO2005100301A1
(en)
*
|
2004-03-31 |
2005-10-27 |
Eli Lilly And Company |
2-aryloxyethyl glycine derivatives and their use as glycine transport inhibitors
|
|
EP1817030A2
(en)
|
2004-12-01 |
2007-08-15 |
Kalypsys, Inc. |
Inducible nitric oxide synthase dimerization inhibitors
|
|
UA95788C2
(en)
|
2005-12-15 |
2011-09-12 |
Ф. Хоффманн-Ля Рош Аг |
Fused pyrrole derivatives
|
|
SI2041088T1
(sl)
|
2006-06-28 |
2014-05-30 |
Amgen Inc. |
Inhibitorji transporter-1 glicina
|
|
MX2010010773A
(es)
|
2008-04-01 |
2011-04-11 |
Abbott Gmbh & Co Kg |
Tetrahidroisoquinolinas, composiciones farmaceuticas que las contienen y su uso en terapia.
|
|
CN101613347B
(zh)
*
|
2008-06-23 |
2012-07-04 |
中国人民解放军军事医学科学院毒物药物研究所 |
胺类化合物及其医药用途
|
|
AR075442A1
(es)
|
2009-02-16 |
2011-03-30 |
Abbott Gmbh & Co Kg |
Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia
|
|
US8877794B2
(en)
*
|
2010-08-13 |
2014-11-04 |
Abbott Laboratories |
Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US9051280B2
(en)
|
2010-08-13 |
2015-06-09 |
AbbVie Deutschland GmbH & Co. KG |
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US8883839B2
(en)
|
2010-08-13 |
2014-11-11 |
Abbott Laboratories |
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US8846743B2
(en)
|
2010-08-13 |
2014-09-30 |
Abbott Laboratories |
Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US9045459B2
(en)
|
2010-08-13 |
2015-06-02 |
AbbVie Deutschland GmbH & Co. KG |
Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US9309200B2
(en)
|
2011-05-12 |
2016-04-12 |
AbbVie Deutschland GmbH & Co. KG |
Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
TW201319049A
(zh)
|
2011-08-05 |
2013-05-16 |
Abbott Gmbh & Co Kg |
胺基□唍、胺基硫□唍及胺基－１，２，３，４－四氫喹啉衍生物，包含彼等之醫藥組合物及彼等於治療之用途
|
|
US9187439B2
(en)
|
2011-09-21 |
2015-11-17 |
Inception Orion, Inc. |
Tricyclic compounds useful as neurogenic and neuroprotective agents
|
|
CN104011028A
(zh)
|
2011-11-18 |
2014-08-27 |
艾伯维德国有限责任两合公司 |
N-取代的氨基苯并环庚烯、氨基四氢化萘、氨基茚满和苯烷基胺衍生物、包含所述衍生物的药物组合物及其在治疗中的用途
|
|
US9365512B2
(en)
|
2012-02-13 |
2016-06-14 |
AbbVie Deutschland GmbH & Co. KG |
Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US9650334B2
(en)
|
2013-03-15 |
2017-05-16 |
Abbvie Inc. |
Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US9656955B2
(en)
|
2013-03-15 |
2017-05-23 |
Abbvie Inc. |
Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
CN105992764A
(zh)
|
2013-10-17 |
2016-10-05 |
艾伯维德国有限责任两合公司 |
氨基色满、氨基硫代色满及氨基-1,2,3,4-四氢喹啉衍生物，包含其的药物组合物及其在治疗中的用途
|
|
EP3057958B1
(en)
|
2013-10-17 |
2019-05-01 |
AbbVie Deutschland GmbH & Co. KG |
Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
CN104098479B
(zh)
*
|
2014-07-28 |
2016-02-10 |
昆明学院 |
含芳环的胺类化合物及其制备方法和应用
|
|
WO2019002173A1
(en)
*
|
2017-06-26 |
2019-01-03 |
Esteve Pharmaceuticals, S.A. |
COMPOUNDS HAVING MULTIMODAL ACTIVITY AGAINST PAIN
|
|
WO2022187206A1
(en)
*
|
2021-03-01 |
2022-09-09 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Dual-target mu opioid and dopamine d3 receptors ligands; preparation and use thereof
|
|
US11596612B1
(en)
|
2022-03-08 |
2023-03-07 |
PTC Innovations, LLC |
Topical anesthetics
|